Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study

Publisher: John Wiley & Sons Inc

E-ISSN: 1539-1612|14|3|205-215

ISSN: 1539-1604

Source: PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol.14, Iss.3, 2015-05, pp. : 205-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract